Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN110452150A reveals a novel one-step synthesis for axial chiral indole-naphthalene compounds offering high purity and significant supply chain cost advantages.
Novel catalyst-free method for 3-selenocyanoindoles using elemental selenium. High yields, scalable process for pharmaceutical and agrochemical manufacturing.
Patent CN107266301A reveals a novel solvent extraction method achieving over 99% purity for acetylacetonate salts, offering significant supply chain and cost advantages.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Novel catalyst-free synthesis of oxadiazaborane derivatives offers rapid room temperature reaction and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN103214492A details a streamlined A3B porphyrin synthesis reducing solvent use and enabling efficient metalloporphyrin catalysis for industrial oxidation.
Patent CN102127038B reveals a selenium-catalyzed route for mono-thioethers. This atmospheric pressure method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110452150B details a novel chiral phosphoric acid catalyzed synthesis of axial chiral indole-naphthalenes, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN115286629B details a magnetic catalytic route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable production capabilities.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Patent CN113511986B enables catalyst-free aryl acetonitrile production. Delivers high purity pharmaceutical intermediates with simplified supply chain and cost efficiency.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Patent CN103254250B introduces a high-efficiency palladium-NHC catalyst enabling mild synthesis of bis(trifluoromethyl) biaryl compounds with broad substrate scope, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.